Loading insider details...
Beta
Latest Form 4 (Aug 7, 2026): Tax Withholding of 4,231 BLCO shares, $70.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 7, 2026 | Bausch & Lomb Corp (BLCO) | Tax Withholding | 4,231 | $70.9K |
| Jun 26, 2026 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/Award | 30,000 | n/a |
| May 26, 2026 | Bausch & Lomb Corp (BLCO) | Tax Withholding | 2,886 | $45.9K |
| Mar 10, 2026 | Bausch & Lomb Corp (BLCO) | Purchase | 14,700 | $252.0K |
| Mar 2, 2026 | Bausch & Lomb Corp (BLCO) | Tax Withholding | 22,059 | $407.9K |
| Feb 27, 2026 | Bausch & Lomb Corp (BLCO) | Grant/Award | 327,102 | n/a |
| Feb 25, 2026 | Bausch & Lomb Corp (BLCO) | Tax Withholding | 65,444 | $1.18M |
| Aug 7, 2025 | Bausch & Lomb Corp (BLCO) | Tax Withholding | 4,231 | $61.1K |
| Jul 23, 2025 | Bausch & Lomb Corp (BLCO) | Grant/Award | 150,000 | n/a |
| Jun 27, 2025 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/Award | 30,000 | n/a |